Kyoto University is set to conduct clinical trials in January using a 3D-printed scaffold derived from umbilical cord tissue for nerve regeneration.
Kyoto University plans to initiate clinical trials in January for a novel approach to nerve regeneration utilizing 3D printing technology. The core of this development is a biocompatible scaffold, created through 3D printing, which is designed to facilitate the regrowth of damaged nerves. This innovative scaffold is derived from umbilical cord-derived mesenchymal stem cells, specifically from a third-party donor.
The research aims to address the challenges associated with nerve repair, particularly in cases of severe nerve damage where natural regeneration is slow or insufficient. The 3D-printed structure is intended to provide a supportive framework, guiding nerve cells to grow and reconnect across the damaged gap. The use of stem cells from umbilical cord tissue offers potential for high viability and differentiation into neural cells.
This initiative represents a significant step in translating advanced additive manufacturing techniques into clinical applications for regenerative medicine. The university's research focuses on creating a precisely engineered environment that mimics the natural extracellular matrix, thereby promoting a more effective and accelerated nerve regeneration process compared to current treatment methods.
This development highlights the growing convergence of 3D printing and regenerative medicine. By creating patient-specific or donor-derived scaffolds with precise micro-architectures, additive manufacturing offers a powerful tool for tissue engineering. This research could lead to improved treatments for nerve injuries, potentially reducing recovery times and improving functional outcomes, and aligns with the broader AM push into biomedical applications.
Edited by the news editor with AI and translated into English from the original report — please refer to the original source.